1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-6 of 6 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialWittert, G.; Bracken, K.; Robledo, K.P.; Grossmann, M.; Yeap, B.B.; Handelsman, D.J.; Stuckey, B.; Conway, A.; Inder, W.; McLachlan, R.; Allan, C.; Jesudason, D.; Fui, M.N.T.; Hague, W.; Jenkins, A.; Daniel, M.; Gebski, V.; Keech, A.
2023Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialRobledo, K.P.; Marschner, I.C.; Handelsman, D.J.; Bracken, K.; Stuckey, B.G.A.; Yeap, B.B.; Inder, W.; Grossmann, M.; Jesudason, D.; Allan, C.A.; Wittert, G.
2022Recovery of Male Reproductive Function After Ceasing Prolonged Testosterone Undecanoate InjectionsHandelsman, D.J.; Desai, R.; Conway, A.J.; Shankara-Narayana, N.; Stuckey, B.G.; Inder, W.J.; Grossmann, M.; Yeap, B.B.; Jesudason, D.; Ly, L.P.; Bracken, K.; Wittert, G.A.
2013Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amountsJesudason, D.; Pedersen, E.; Clifton, P.
2003Macrovascular risk and diagnostic criteria for type 2 diabetes - Implications for the use of FPG and HbA1c for cost-effective screeningJesudason, D.; Leong, D.; Dunstan, K.; Wittert, G.
2014Utility of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in obese diabetic individuals before and after weight lossJesudason, D.; Pedersen, E.; Clifton, P.

Discover